IPOGrid
0002130959
IPO filing research

RZ Wellness Ltd

Wholesale-Drugs, Proprietaries & Druggists' Sundries

ipo amended OTCQB S-1/A

RZ Wellness Ltd IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: S-1/A on 2026-08-26. Current deal snapshot: exchange OTCQB.

Filing Timeline

SEC EDGAR
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
First tracked pre-IPO filing for this issuer.
Price $0.03 · 5,500,000 shares · Gross proceeds $165,000
common stock · Exchange OTCQB · Use of proceeds To cover offering expenses · Flags self_underwritten, best_efforts · Underwriters self-underwritten
RZ Wellness Ltd's S-1/A filing provides updated financial disclosures, including revised segment reporting, accounting standard evaluations, and detailed financial statements as of December 31, 2025. The company operates in a single geographic segment (Malaysia) and reports consolidated financials with a focus on trading activities. Key updates include evaluation of ASU 2025-05 for credit losses, changes in accrued liabilities, and a net loss for the year ended December 31, 2025. The filing also includes unaudited quarterly financials as of March 31, 2026.
2026-08-26 · 0002130959-26-000007
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
Price $0.03 · 5,500,000 shares · Gross proceeds $165,000
Common Stock · Exchange OTCQB · Use of proceeds to cover offering expenses and related costs · Flags foreign_private_issuer, best_efforts · Underwriters self-underwritten
RZ Wellness Ltd is preparing for its initial public offering (IPO) with an S-1 filing dated July 20, 2026. The filing includes unaudited financial data as of March 31, 2026, showing a $10,374 net loss for the first quarter of 2026 compared to a $8,582 loss in the same period in 2025. The company operates in a single geographic segment (Malaysia) and reports a single business segment (trading of products) as of 2025, shifting from two segments in 2024. Key financial highlights include a $63,177 total asset base as of March 2026, with significant concentrations in accounts receivable ($49,967) and accrued liabilities ($21,770). The company is evaluating new accounting standards (e.g., ASU 2025-05) and maintains a full valuation allowance on deferred tax assets due to ongoing losses and economic uncertainties.
2026-07-20 · 0002130959-26-000005
Comparable Deals

1 comparable deal

Consumer StaplesMicro (<$50M)Last 18 months
Only 0 strict matches; expanded to 1 using nearest neighbors.
-2.5%
Median day-1
0%
Above issue
+6.8%
Median week-1
-2.5%
Downside (p10)

Recent News

No recent news stored for this issuer.